InterOcean Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$5.3M Buy
6,817
+233
+4% +$166K 0.13% 104
2023
Q4
$3.84M Buy
6,584
+997
+18% +$582K 0.1% 115
2023
Q3
$3M Buy
5,587
+18
+0.3% +$9.28K 0.09% 116
2023
Q2
$2.61M Buy
5,569
+137
+3% +$57.5K 0.08% 115
2023
Q1
$1.87M Buy
5,432
+403
+8% +$136K 0.06% 132
2022
Q4
$1.84M Sell
5,029
-2
-0% -$709 0.07% 132
2022
Q3
$1.63M Sell
5,031
-434
-8% -$138K 0.07% 127
2022
Q2
$1.77M Buy
5,465
+2,888
+112% +$867K 0.07% 124
2022
Q1
$738K Buy
2,577
+501
+24% +$129K 0.03% 143
2021
Q4
$573K Sell
2,076
-773
-27% -$196K 0.02% 162
2021
Q3
$658K Hold
2,849
0.03% 138
2021
Q2
$654K Buy
2,849
+61
+2% +$12.3K 0.03% 141
2021
Q1
$521K Buy
2,788
+40
+1% +$7.82K 0.03% 148
2020
Q4
$464K Buy
+2,748
New +$410K 0.03% 137

Other funds holding LLY

InterOcean Capital Group's LLY Position: Q1 2024 in Review

InterOcean Capital Group increased its Eli Lilly (LLY) stake by 3.5% in Q1 2024, buying an estimated $166K and bringing the position to 6,817 shares worth $5.3M. The position accounts for 0.13% of the portfolio, ranked #104.

InterOcean Capital Group first reported a position in LLY in Q4 2020 and has held it in 14 quarters since. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • InterOcean Capital Group held 6,817 shares of Eli Lilly worth $5.3M as of Q1 2024.
  • InterOcean Capital Group bought 233 Eli Lilly shares in Q1 2024, an estimated $166K.
  • Eli Lilly made up 0.13% of InterOcean Capital Group's portfolio in Q1 2024, its #104 holding.
  • InterOcean Capital Group first reported a position in Eli Lilly in Q4 2020 and has held it in 14 quarters since.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.